Hematologic Malignancy
Adult Acute Promyelocytic Leukemia
CI-CAN-00008690Explore in graph →
Hematologic
- NCIt
- C208353
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008690Explore in graph →
Clinical trials
28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01548911 | Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia | withdrawn | Phase 2 | 0 | Wake Forest University Health SciencesOTHER | 0 | Jul 2, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jul 2, 2018source: clinicaltrials